CM
ITCI

Caption Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Caption Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-618
Closed -$42.3K – 1654
2024
Q2 		$42.3K Sell
618
-266,162
-100% -$18.5M ﹤0.01% 1062
2024
Q1 		$18.5M Buy
266,780
+226,783
+567% +$15.6M 0.28% 80
2023
Q4 		$2.86M Buy
+39,997
New +$2.3M 0.04% 510
2023
Q1 		– Sell
-12,205
Closed -$590K – 1652
2022
Q4 		$646K Buy
12,205
+5,500
+82% +$276K 0.01% 864
2022
Q3 		$312K Buy
+6,705
New +$350K ﹤0.01% 1175
2022
Q1 		– Sell
-17,144
Closed -$898K – 2048
2021
Q4 		$898K Sell
17,144
-26,235
-60% -$1.1M 0.01% 1084
2021
Q3 		$1.62M Buy
43,379
+33,319
+331% +$1.16M 0.02% 852
2021
Q2 		$411K Buy
10,060
+2,260
+29% +$83.5K 0.01% 1091
2021
Q1 		$265K Sell
7,800
-23,700
-75% -$822K 0.01% 888
2020
Q4 		$1M Sell
31,500
-28,173
-47% -$740K 0.02% 610
2020
Q3 		$1.53M Buy
59,673
+6,623
+12% +$151K 0.04% 513
2020
Q2 		$1.36M Buy
+53,050
New +$1.07M 0.05% 460
2019
Q2 		– Sell
-80,000
Closed -$1.03M – 860
2019
Q1 		$975K Buy
+80,000
New +$1.02M 0.05% 357

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Caption Management's ITCI Position: Q3 2024 in Review

Caption Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 618 shares — an estimated $42.3K sold.

Caption Management first reported a position in ITCI in Q1 2019 and held it in 13 quarters. The position peaked at $18.5M in Q1 2024. 354 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

  • Caption Management reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 618 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $42.3K.
  • Caption Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2019 and held it in 13 quarters.
  • Caption Management's Intra-Cellular Therapies Inc. position peaked at $18.5M in Q1 2024.
  • 354 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.